BioLight Announces Collaboration with Ora, Inc. for TeaRx™ Multi-Parameter Diagnostic Test for Dry Eye Syndrome

BioLight today announced that it has expanded its relationship with Ora, Inc., a world-leading independent, full-service ophthalmic contract research organization and product development firm, via the signing of a collaboration agreement pursuant to which the companies will work together to advance the clinical, regulatory and commercial development of BioLight’s TeaRx™ multi-parameter diagnostic test for dry eye syndrome.

Link to complete article

Link to Newsroom

Comments are closed.